Dr. Wright joins Ring from AavantiBio, where he served as chief medical officer. He has also served as chief medical officer of Cyclerion Therapeutics and senior vice president and chief development officer of Ironwood Pharmaceuticals, according to a Jan. 30 news release from Ring Therapeutics.
Dr. Wright currently serves as a medical adviser to Cyclerion and on the board of directors for Alkermes.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
